We synthesized a potent and selective antagonist radioligand for the n
eurokinin (NK)-1 receptor and characterized its binding to guinea pig
striatal membranes. (R) - N - [2 - [Acetyl[H-3(3)][(2 - methoxyphenyl)
methyl]amino] - 1 - (1H - indol - 3 - ylmethyl) ethyl][1,4' - bipiperi
dine] - 1'-acetamide ([H-3]LY303870) binds to a single class of sites
with an equilibrium K-D of 0.22 nM and a B-max of 723 fmol/mg of prote
in. Unlabeled LY303870 potently inhibited the binding with an IC50 of
0.56 nM, whereas the less active (S)-enantiomer (LY306155) was substan
tially less potent. The nonpeptide NK-1 antagonists (+/-)-CP96,345 and
(+/-)-RP 67580 had IC50 values of 0.74 and 49 nM, respectively. Subst
ance P (SP) was also a potent inhibitor with with an IC50 of 3.1 nM. T
he inhibition by SP could be separated into two components: a high-aff
inity component with a K-i of 0.53 nM and a lower-affinity component w
ith a K-i of 155 nM. Addition of 100 mu M guanylyl 5'-imidodiphosphate
[Gpp(NH)pl in the incubation increased the relative amount of the low
-affinity agonist state of the receptor. Consistent with the antagonis
t properties of LY303870, the dissociation rate of [H-3]-LY303870 was
not changed by the presence of 100 mu M Gpp(NH)p. The distribution of
[H-3]LY303870 binding sites in the guinea pig brain closely matched th
e distribution of NK-1 receptors labeled by [H-3]SP. Therefore, [H-3]L
Y303870 is a potent and selective antagonist radioligand for NK-1 rece
ptors in guinea pig brain. In addition, regulation of NK-1 agonist aff
inity by guanine nucleotides is similar to that seen for monoaminergic
receptors.